With its high concentration of talented engineers, innovators, and entrepreneurs, it’s no surprise innovation is thriving in Israel. Home to a growing number of biotech and engineering firms, Israel has established a thriving ecosystem for ophthalmology startups.

This week’s podcast shines a spotlight on that ecosystem, as host Suzana Nahum Zilberberg, Vice Chair of Bio-Light Life Sciences and co-founder of healthcare advisory firm iL.factor, settles in for a series of six-minute chats with six Israel-based innovators.

Tune in to hear emerging technology founders, industry leaders, and savvy investors discuss emerging trends, product advancements, and business developments in eye care.

The lineup includes:

Zack Dvey-Aharon, PhD, cofounder and CEO of AEYE Health, and Kester Nahen, CEO of Notal Vision. The two early startup founders discuss how disruptive technology can help clinic-based eyecare overcome its limitations. They also give sage advice for other entrepreneurs.

Anat Loewenstein, MD, Chair, Department of Ophthalmology, Tel Aviv Medical Center; Professor of Ophthalmology, Incumbent of the Sydney A. Fox Chair in Ophthalmology, and Vice Dean of the Faculty of Medicine, Tel Aviv University in Israel, and Ron Schneider, CEO and cofounder of Beyeonics Surgical. The key opinion leaders discuss the advantages of translating defense technologies to medicine, and the key to a successful transition.

Nahum Ferera, CEO and cofounder of EyeYon Medical, and Michal Geva, Managing Partner and cofounder of Triventures. Geva, the first woman to found and manage a VC in Israel, discusses the opportunities and challenges in Israel’s ecosystem. Ferera recently completed a successful first round and discusses how he made it happen—with the help of a global team.